Mineralys Therapeutics, Inc. (MLYS)
20.53
+0.23
(+1.13%)
USD |
NASDAQ |
Oct 19, 14:20
Mineralys Therapeutics Market Cap : 1.814B for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.794B |
| October 15, 2026 | 1.912B |
| October 14, 2026 | 1.834B |
| October 13, 2026 | 1.855B |
| October 12, 2026 | 1.964B |
| October 09, 2026 | 2.065B |
| October 08, 2026 | 1.977B |
| October 07, 2026 | 1.952B |
| October 06, 2026 | 1.939B |
| October 05, 2026 | 2.059B |
| October 02, 2026 | 2.088B |
| October 01, 2026 | 2.096B |
| September 30, 2026 | 2.220B |
| September 29, 2026 | 2.163B |
| September 28, 2026 | 2.264B |
| September 25, 2026 | 2.285B |
| September 24, 2026 | 2.349B |
| September 23, 2026 | 2.376B |
| September 22, 2026 | 2.598B |
| September 21, 2026 | 2.501B |
| September 18, 2026 | 2.476B |
| September 17, 2026 | 2.472B |
| September 16, 2026 | 2.433B |
| September 15, 2026 | 2.554B |
| September 14, 2026 | 2.558B |
| Date | Value |
|---|---|
| September 11, 2026 | 2.492B |
| September 10, 2026 | 2.589B |
| September 09, 2026 | 2.695B |
| September 08, 2026 | 2.749B |
| September 04, 2026 | 2.492B |
| September 03, 2026 | 2.498B |
| September 02, 2026 | 2.566B |
| September 01, 2026 | 2.259B |
| August 31, 2026 | 2.268B |
| August 28, 2026 | 2.262B |
| August 27, 2026 | 2.298B |
| August 26, 2026 | 2.287B |
| August 25, 2026 | 2.327B |
| August 24, 2026 | 2.233B |
| August 21, 2026 | 2.266B |
| August 20, 2026 | 2.275B |
| August 19, 2026 | 2.381B |
| August 18, 2026 | 2.351B |
| August 17, 2026 | 2.302B |
| August 14, 2026 | 2.265B |
| August 13, 2026 | 2.305B |
| August 12, 2026 | 2.390B |
| August 11, 2026 | 2.415B |
| August 10, 2026 | 2.419B |
| August 07, 2026 | 2.416B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 7.988B |
| Oncolytics Biotech, Inc. | 62.73M |
| Sangamo Therapeutics, Inc. | 45.65M |
| Sarepta Therapeutics, Inc. | 1.871B |
| Anixa Biosciences, Inc. | 91.99M |
Market Cap Related Metrics
| PEG Ratio | -0.2546 |
| Price to Book Value | 3.292 |
| Price | 20.53 |
| Earnings Yield | -20.67% |
| PEGY Ratio | -0.2546 |